Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.
about
Transcriptome profiling reveals miR-9-3p as a novel tumor suppressor in gastric cancerLoss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies.MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis.Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124/IL-6R/STAT3 axis.Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment.Progression inference for somatic mutations in cancer.MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.Inhibition of LHX2 by miR-124 suppresses cellular migration and invasion in non-small cell lung cancer.Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysisClinicopathological Significance of Elevated PIK3CA Expression in Gastric Cancer.Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.MiR-646 inhibited cell proliferation and EMT-induced metastasis by targeting FOXK1 in gastric cancer.The tumor suppressor role of miR-155-5p in gastric cancer.
P2860
Q33913929-37D440C2-A901-4D92-894C-EA269B825572Q37050045-CA37FF60-4313-4A4A-AC32-47227F34FFFFQ37057844-914DD416-1AC2-41FD-A535-49C3D83516F2Q37400105-0EF88088-00AD-45A5-8595-E8CDB42EF054Q37665344-2CF9B23C-1E43-41E3-B42F-CDDCD74BE89DQ38793244-3EABC15F-C726-4694-9906-0B0DE5944DBAQ38813857-F95F151D-C3F0-4DD7-9DEA-983A0C85AC59Q40421665-410C3B84-09CD-4DC1-B246-A56E0069296AQ41619711-D083B14E-FC8F-4689-8538-264319A03A79Q42050401-CF5F5574-B791-4119-B6CC-8C12ABF11487Q42143948-0F8DD5F6-6413-4A9A-B766-2F8E921369AFQ49461890-BC4B1154-FA99-4F54-86F8-60A1C5EA2A20Q50063155-90AE2B95-9FEB-422B-AE5E-F91EFF79FA13Q50575842-B505BCDB-AE75-4A20-94B4-235DF1B3B3DAQ55691713-24DBA45C-F252-41AE-AD66-07B38A0DF1F2
P2860
Deregulation of ARID1A, CDH1, cMET and PIK3CA and target-related microRNA expression in gastric cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@ast
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@en
type
label
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@ast
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@en
prefLabel
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@ast
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Deregulation of ARID1A, CDH1, ...... expression in gastric cancer.
@en
P2093
Andrés Cervantes
Cristina Mongort
Maider Ibarrola-Villava
Marta J Llorca-Cardeñosa
Noelia Tarazona
Samuel Navarro
Tania Fleitas
P2860
P304
26935-26945
P356
10.18632/ONCOTARGET.4775
P407
P577
2015-07-27T00:00:00Z